Clinical utility study shows benefit of PromarkerD testing
Filed with ASX · · 4 pages · English
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- Proteomics contracts Biotem to manufacture PromarkerD kits
- Proteomics to collaborate to validate test for endometriosis
- June 2021 Quarterly Activities Report and Appendix 4C
- Proteomics engages Abcam to manufacture PromarkerD reagents
- Study shows diabetes drug improves PromarkerD risk scores
Later from Proteomics International Laboratories
- September 2021 Quarterly Activities Report and Appendix 4C
- Proteomics awarded $100,000 manufacturing funding
- PromarkerD outperforms standard of care tests for DKD
- PromarkerD distribution network expands to Britain
- Proteomics receives $1.2 million in R&D tax incentive
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories